Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Mar;178(6):1253-1256.
doi: 10.1111/bph.15348.

Recent advances in the pathogenesis and therapeutics of amyotrophic lateral sclerosis

Javier Fernández-Ruiz  1 , Eva de Lago  1 , Carmen Rodríguez-Cueto  1 , María A Moro  2
Affiliations
Free article
Editorial

Recent advances in the pathogenesis and therapeutics of amyotrophic lateral sclerosis

Javier Fernández-Ruiz et al. Br J Pharmacol. 2021 Mar.
Free article

Erratum in

  • Correction.
    [No authors listed] [No authors listed] Br J Pharmacol. 2021 May;178(10):2162. doi: 10.1111/bph.15454. Br J Pharmacol. 2021. PMID: 33932232 No abstract available.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Buratti, E. (2020). Targeting TDP-43 proteinopathy with drugs and drug-like small molecules. British Journal of Pharmacology, 178, 1298-1315. https://doi.org/10.1111/bph.15148
    1. Fernández-Ruiz, J. (2019). The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes. British Journal of Pharmacology, 176, 1370-1383. https://doi.org/10.1111/bph.14382
    1. Herrando-Grabulosa, M., Gaja-Capdevila, N., Vela, J. M., & Navarro, X. (2020). Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis. British Journal of Pharmacology, 178, 1336-1352. https://doi.org/10.1111/bph.15224
    1. Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020). ALS genetics: Gains, losses, and implications for future therapies. Neuron, 108, 822-842. https://doi.org/10.1016/j.neuron.2020.08.022
    1. Klingl, Y. E., Pakravan, D., & Van Den Bosch, L. (2020). Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis. British Journal of Pharmacology, 178, 1353-1372. https://doi.org/10.1111/bph.15217

Publication types

MeSH terms